Immunotherapy and Colorectal Cancer – Part 1

In the last several months, there has been significant media coverage about the role of immunotherapy treatments for cancer.  The report on 60 Minutes in December noted there are the business and political aspects of immunotherapy development, which are common to most medical breakthroughs. The recent Cancer Film series on PBS, the Emperor of All Maladies, focused…  Read More

First-Line Treatment Approved for Stage IV Colorectal Cancer

There is new first-line treatment (standard of care to start treatment) giving as many as 60% of the stage IV colorectal cancer patients more options for treatment. Previously, most stage IV patients undergoing chemotherapy would be recommended to go on FOLFOX and bevacizumab (Avastin). Patients would receive this first set of drugs (called first-line) and if…  Read More